panel questions and discussion (28of35) complex generics – sep. 25-26, 2019
Published 4 years ago • 181 plays • Length 25:03
Download video MP4
Download video MP3
Similar videos
-
45:51
panel questions and discussion (35of35) complex generics – sep. 25-26, 2019
-
35:57
questions and answers (4of35) complex generics – sep. 25-26, 2019
-
28:18
questions and answers (17of35) complex generics – sep. 25-26, 2019
-
42:51
questions and answers (22of35) complex generics – sep. 25-26, 2019
-
29:41
questions and answers (13of35) complex generics – sep. 25-26, 2019
-
14:48
comparative analyses: injectable combination products (21of35) complex generics – sep. 25-26, 2019
-
9:09
panel questions and discussion (17of33) quality – oct. 16-17, 2019
-
20:49
complex peptide andas: test/reference comparability (11of35) complex generics – sep. 25-26, 2019
-
19:07
be approaches for long acting drug products (14of35) complex generics – sep. 25-26, 2019
-
22:03
quality view on injectable product considerations (20of35) complex generic drugs – sep. 25-26, 2019
-
25:59
questions and panel discussion (16of39) complex generics 2018
-
20:30
quality for transdermal delivery systems (8of35) complex generic drugs – sep. 25-26, 2019
-
11:10
what constitutes complex drug-device combination (18of35) complex generics – sep. 25-26, 2019
-
30:23
pre-anda program update (2of35) complex generics– sep. 25-26, 2019
-
17:44
overview of comparative analyses - clinical perspective (19of35) complex generics – sep. 25-26, 2019
-
23:49
questions and answers (9of35) complex generic drugs – sep. 25-26, 2019
-
22:00
panel discussion orally inhaled and nasal drug products (38of39) complex generics 2018
-
15:13
comparative analyses: device and user interface (25of35) complex generics– sep. 25-26, 2019
-
16:13
be for bridging studies with orally inhaled/nasal drugs (26of35) complex generics – sep. 25-26, 2019
Clip.africa.com - Privacy-policy